Molbio Diagnostics IPO has been subscribed 0.00 times overall as of day 1. The retail portion has been subscribed 0.00 times, QIBs [Ex Anchor] 0.00 times, and NIIs 0.00 times.
Molbio Diagnostics IPO will open for subscription on August 10, 2026, and close August 12, 2026.
Molbio Diagnostics IPO Reserved In this IPO 0% shares are reserved for QIBs, 50% for NIIs and 50% for the retail category i.e. RIIs. To know the Molbio Diagnostics IPO subscription status, you can check the subscription data live given below.
Molbio Diagnostics IPO Subscription Live [Day 1]
| Category | Share Offerd | Share Bid For | Subscribed |
|---|---|---|---|
| QIB [Ex Anchor] | |||
| NII | |||
| bNII [>10L] | |||
| sNII [<10L] | |||
| RII | |||
| Total |
Read Also: Molbio Diagnostics IPO GMP Today
Molbio Diagnostics IPO Day Wise Subscription Data
Molbio Diagnostics IPO Subscription data is automatically saved by day when the subscription expires after 6:00 pm in the table below.
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB [Ex Anchor] | 0.00x | 0.00x | 0.00x |
| NII | 0.00x | 0.00x | 0.00x |
| bNII [>10L] | 0.00x | 0.00x | 0.00x |
| sNII [<10L] | 0.00x | 0.00x | 0.00x |
| RII | 0.00x | 0.00x | 0.00x |
| Total | 0.00x | 0.00x | 0.00x |
Molbio Diagnostics IPO [Share Offerd]
| Category | Shares | Ammount |
|---|---|---|
| Anchor Investors | ₹ Cr. | |
| QIB [Ex Anchor] | ₹ Cr. | |
| NII | ₹ Cr. | |
| bNII [>10L] | ₹ Cr. | |
| sNII [<10L] | ₹ Cr. | |
| RII | ₹ Cr. | |
| ₹ Cr. | ||
| Total | ₹ Cr. |
Types of Molbio Diagnostics IPO Subscription
There are mainly three categories of subscription for Molbio Diagnostics IPO, which are determined based on the type of investor applying:
- Retail Investors (RI):
- Retail Investors are individual investors who apply for the IPO shares for their personal accounts, typically in amounts that do not exceed a specified limit (usually ₹2 lakh).
- This category is highly important for IPOs, as retail investors often comprise a significant portion of the total demand.
- If the IPO is oversubscribed in this category, the allotment is done via a lottery system, where each retail investor has an equal chance of receiving shares.
- Qualified Institutional Buyers (QIBs):
- QIBs are institutional investors such as mutual funds, insurance companies, and pension funds. They are typically large entities with significant capital to invest in the IPO.
- The QIB category often gets a significant portion of the overall offering, and it’s considered a critical factor for the success of the IPO.
- The subscription rate for QIBs is usually higher than for retail investors, and they generally receive priority in allotment.
- Non-Institutional Investors (NIIs):
- NIIs include high-net-worth individuals (HNIs) or corporates that apply for IPO shares in larger quantities, typically exceeding ₹2 lakh.
- Like QIBs, the NII category is a significant driver of an IPO’s success, especially if the retail category is under-subscribed.
- They are generally allocated shares after the retail and QIB categories have been allotted, and sometimes the shares allotted to this category may be on a pro-rata basis if there is oversubscription.
Molbio Diagnostics IPO Subscription Status FAQs
How much subscribed of Molbio Diagnostics IPO Day 1?
As of Day 1, Molbio Diagnostics IPO has been subscribed 0.00x for all category.
What is Molbio Diagnostics IPO retail subscription status?
Retail category of Molbio Diagnostics IPO subscribed 0.00x.
How do I check Molbio Diagnostics IPO subscription status Live Data?
Visit our Molbio Diagnostics IPO subscription status page for real time bidding data and investor category updates.
When Molbio Diagnostics IPO will be listed?
The Molbio Diagnostics IPO listing date is August 17, 2026 on BSE & NSE
Disclaimer: Readers are strongly advised to seek guidance from a qualified financial advisor before making any investment decisions. Relying solely on the content presented here for financial choices is done entirely at the reader’s own risk.
| Thank You… |
|---|
Share the post "Molbio Diagnostics IPO Subscription Status (Live Update) 2026"